SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as investors digest a major revenue beat alongside the announcement of massive long-term hyperscaler contracts, fueling intense debate between bulls who see a scaling cash-flow machine and bears concerned about capital expenditure and dilution. The community is focused on the company's aggressive infrastructure buildout timeline and the potential for these contracted revenue milestones to drive long-term value despite broader market volatility.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing intense scrutiny as FDA briefing documents ahead of the advisory committee meeting highlight concerns regarding statistical analysis plan modifications, leading to a significant market sell-off. Community members are actively debating whether these discrepancies represent data manipulation, as the FDA suggests, or a breakdown in regulatory communication and administrative incompetence regarding the validity of the final trial plan.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as investors react to escalating geopolitical tensions, uncertain AI sector spending, and mixed earnings reports from major tech companies. Community discourse remains deeply divided between those panicking over potential macroeconomic downturns and others aggressively buying the dip, anticipating a rebound driven by long-term data center infrastructure demand.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple is experiencing intense community focus as traders closely monitor legislative progress regarding the proposed Clarity Act, with many investors debating whether the bill's outcome will serve as a definitive catalyst for institutional adoption or if the uncertainty will lead to continued volatility. While some participants are actively accumulating positions in anticipation of a potential regulatory breakthrough, others express skepticism and frustration, highlighting a stark divide between those betting on long-term utility and those wary of current price stagnation.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending sharply lower amid investor anxiety regarding the sustainability of AI-related circular financing deals and potential credit risks associated with massive data center buildouts. The community is actively debating whether this volatility represents a fundamental breakdown in the AI narrative or a temporary capitulation event driven by high-profile short-selling and sector-wide rotation.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending amid significant market volatility as investors debate the sustainability of AI infrastructure spending and its impact on semiconductor valuations. The community remains deeply divided between those betting on long-term growth driven by new AI hardware partnerships and those anticipating a sharp correction due to concerns over bloated PE ratios and macroeconomic headwinds.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing heightened volatility as investors grapple with a combination of intensifying geopolitical tensions in the Middle East and concerns over the sustainability of AI-driven capital expenditures. Market participants are actively debating the timing of potential Federal Reserve rate adjustments and monitoring the impact of a sharp downturn in the South Korean KOSPI index on broader technology valuations.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense volatility and a sharp sell-off driven by fears of increased competition from Chinese memory manufacturers and concerns over the sustainability of the current chip supercycle. Community members remain deeply divided, with many debating whether this is a structural shift in memory demand or an overreaction providing a generational buying opportunity ahead of upcoming earnings.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF ($SOXX) is currently facing significant selling pressure as investors scrutinize AI capital expenditure sustainability and rotate capital toward broader technology holdings. The community is actively debating whether this double-digit correction represents a healthy reset for a crowded trade or the beginning of a deeper bearish trend driven by macroeconomic headwinds and valuation concerns.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

MapLight Therapeutics Inc.

MapLight Therapeutics is seeing intense volatility after its Phase 2 schizophrenia trial yielded mixed results, with investors sharply divided on whether the significant sell-off is an overreaction to the missed endpoint or a justified response to the trial data. Community members are actively debating the company's valuation, cash position, and institutional ownership while weighing the prospects of a potential recovery against the inherent risks of biotech value traps.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Securities Fraud Investigation Into Capricor Therapeutics, Inc. (CAPR) Announced Following Critical FDA Review Ahead of Advisory Committee Meeting Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Capricor Therapeutics, Inc. (Capricor or the Company) (NASDAQ: CAPR) on behalf of investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CAPRICOR THERAPEUTICS, INC...

CAPR Stock On Track For Worst Day Ever — Analysts Divided On Deramiocel’s Approval Probability After FDA Documents Paint ‘Ugly Picture’ 

Equity

The documents released by the FDA on Monday, ahead of an advisory committee meeting to review Capricor’s application for Deramiocel, have raised a divide among Wall Street experts over what to expect.


Capricor Therapeutics Shares Dive Before Key Review as FDA Panel Challenges Data

FDA briefing documents question Capricor's deramiocel efficacy in DMD, while the company defends its trial analysis ahead of July 29.read more...

QUICK SPARK: Capricor Stock Dives  'Complete Fraud' Says Pharma Bro Martin Shkreli

Martin Shkreli accuses Capricor Therapeutics of fraud and predicts legal action against its CEO and consultant over patient data.read more...

Capricor Says FDA Used 'Obsolete' Analysis In Deramiocel Review – CAPR Stock Plummets After Agency Released Briefing Document

The FDA released briefing documents, raising concerns over whether Capricor’s lead therapy, Deramiocel, has demonstrated sufficient effectiveness in treating cardiomyopathy in patients with Duchenne muscular dystrophy.


Capricor Therapeutics Stock Plunges After FDA Releases Briefing Documents

Capricor Therapeutics fell over 60% Monday after the FDA posted briefing documents ahead of the company's July 29 advisory committee meeting.read more...

FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions

The days ahead pack several binary or near-binary catalysts for U.S. biotech and biopharma companies—decisions that could sharply reshape valuations overnight.


CAPR Stock On Track To Clock Weekly Gains Ahead Of Critical FDA Panel — Retail Deems It A ‘Binary Event’

An FDA advisory committee will review Capricor’s application for Deramiocel on July 29.


CAPR Stock Eyes 1st Weekly Gain In 5 Weeks: Capricor’s DMD Therapy Faces FDA Panel Review Next Week, Retail Sees 'Excellent Opportunity'

The Food and Drug Administration’s Advisory Committee is scheduled to meet on July 29 to review Capricor’s Biologics License Application for Deramiocel.


CAPR Stock Hits Over 4-Month Low: Capricor Execs Cash In $1.5M As FDA Sets Stage For DMD Drug Review 

Capricor is working toward a potential FDA decision by Aug. 22, making the next two months a key regulatory stretch for CAPR investors.

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

The Fed's July 28-29 meeting has markets debating a hold versus a hike, not a cut, with CME FedWatch pricing roughly a 65% chance of no change and rising odds of a September rate increase amid inflation running well above the 2% target. What do you expect the Fed to decide? Drop a comment with when you expect the first cut/hike to be.

What do you expect the Fed to decide at its FOMC meeting?  
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

The FDA’s removed briefing docs and accusations of statistical 'p-hacking' have left investors in limbo ahead of a volatile Wednesday meeting.

Conflict persists over whether data should be judged by the original draft protocol or the final version updated after the inclusion of Cohort B.

Frustrated investors are organizing email and phone campaigns to reach senators like Ron Johnson to protest FDA transparency and handling of the trial.

Bulls are calling out 'hypersensitivity' concerns as AI-generated nonsense that ignores the critical need for an effective treatment for DMD.

Current Price	$7.00
Prev Close	$19.70
Open	$5.87
Dividend Yield	0.00%
50-Day Moving Average	$24.99
Beta	1.16
Avg. Volume	1.42M
PE Ratio	-3.02

52-Week High	$40.37
52-Week Low	$4.30
Market Capitalization	$1.14B
EPS (Annual)	-$2.26
Price to Book	1.45
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

CAPRCapricor Therapeutics Inc

Latest CAPR News